Core Insights - The animal health sector experienced a slight increase of 0.46% on September 29, with Shenlian Biological leading the gains [1] - The Shanghai Composite Index closed at 3862.53, up 0.9%, while the Shenzhen Component Index closed at 13479.43, up 2.05% [1] Stock Performance - Shenlian Biological (688098) closed at 10.59, up 1.92% with a trading volume of 68,700 shares and a turnover of 72.32 million yuan [1] - Other notable performers included: - Biological Shares (600201) at 9.48, up 1.50% with a turnover of 503 million yuan [1] - Pulaike (603566) at 13.78, up 1.03% with a turnover of 54.30 million yuan [1] - Zhongmu Shares (600195) at 7.12, up 0.85% with a turnover of 49.02 million yuan [1] Capital Flow - The animal health sector saw a net outflow of 7.69 million yuan from institutional investors, while retail investors contributed a net inflow of 8.08 million yuan [2] - The detailed capital flow for key stocks includes: - Shenlian Biological: net outflow of 5.50 million yuan from retail investors [3] - Biological Shares: net outflow of 7.67 million yuan from retail investors [3] - Pulaike: net outflow of 4.08 million yuan from retail investors [3]

Group 1 - The core point of the article is that Xianfeng Holdings announced the decision to exit the feed business through the termination of agreements with various companies [1] - The company’s subsidiary, Zunyi Kangxiyuan Animal Nutrition Technology Co., Ltd., has signed a lease contract and sales agreements with several entities, which are now being terminated [1] - The decision was made after friendly negotiations among the parties involved, and the transition will be completed gradually after the agreements are signed [1]

Group 1 - The company, Xianfeng Holdings (002141), announced on the evening of September 26 that it and its controlling subsidiaries have no overdue guarantees, no guarantees involved in lawsuits, and no guarantees that it should bear due to being judged to lose a lawsuit [1]

Core Viewpoint - The animal health sector experienced a rise of 1.59% on September 26, with Bio-Pharmaceuticals leading the gains, while the overall market indices, Shanghai Composite and Shenzhen Component, saw declines of 0.65% and 1.76% respectively [1] Group 1: Market Performance - The animal health sector's individual stock performance showed significant variations, with Bio-Pharmaceuticals closing at 9.34, up by 7.23%, and a trading volume of 1.0367 million shares, resulting in a turnover of 973 million yuan [1] - Other notable performers included Huisheng Biological at 20.68, up by 1.87%, and Ruipu Biological at 20.93, up by 1.60% [1] Group 2: Capital Flow - The animal health sector saw a net inflow of 86.5157 million yuan from institutional investors, while retail investors experienced a net outflow of 44.7995 million yuan [2] - The capital flow data indicates that major stocks like Bio-Pharmaceuticals had a net inflow of 12.63% from institutional investors, despite a significant outflow from retail and speculative investors [3]

Group 1 - The core point of the article is that Xianfeng Holdings announced its total guarantee amount and the composition of its revenue for the first half of 2025, highlighting its financial stability and business segments [1] Group 2 - As of the announcement, the total guarantee amount provided by the company and its subsidiaries is 140 million yuan, which accounts for 17.07% of the latest audited net assets [1] - The total balance of guarantees provided to off-balance sheet entities is 20 million yuan, representing 2.44% of the latest audited net assets [1] - The company and its subsidiaries have no overdue guarantees, litigation-related guarantees, or guarantees due to adverse judgments [1] Group 3 - For the first half of 2025, the revenue composition of Xianfeng Holdings is as follows: electronic materials account for 57.48%, feed accounts for 35.4%, other products account for 3.92%, and bioproducts account for 3.2% [1] - The current market capitalization of Xianfeng Holdings is 3.9 billion yuan [1]

Group 1 - The core point of the article is that Xianfeng Holdings (002141.SZ) announced its subsidiary, Zunyi Kangxiyuan Animal Nutrition Technology Co., Ltd. (referred to as "Kangxiyuan"), plans to exit the feed business by terminating existing agreements with related parties [1] - Kangxiyuan has previously signed a feed factory lease contract with Zunyi Riquan Feed Biotechnology Co., Ltd. and its shareholder, Guangdong Tiannong Group Co., Ltd., along with feed purchase and sales agreements with several other companies [1] - The company's board of directors has authorized the chairman or a designated agent to sign the termination agreements and handle subsequent matters related to the exit from the feed business [1]

关于为控股子公司向银行借款事项 提供担保和反担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 （一）担保情况 贤丰控股股份有限公司 证券代码：002141 证券简称：贤丰控股 公告编号：2025-074 因业务发展需要，贤丰控股股份有限公司（简称"公司"）的控股子公司成 都史纪生物制药有限公司（以下简称"史纪生物"）拟通过自身及担保公司向银 行申请不超过人民币 2,000 万元的流动资金借款，公司、史纪生物就史纪生物借 款事项提供担保和反担保。具体如下： 1. 担保事项一：史纪生物拟向成都农村商业银行股份有限公司龙泉驿洪河 分理处申请 800 万元流动资金借款，借款期限 1 年，借款利率以银行借款合同为 准。成都小企业融资担保有限责任公司（以下简称："担保公司"）就该笔借款 为史纪生物提供连带责任保证担保，史纪生物以其持有房产提供抵押担保和反担 保。基于上述借款及担保情况，公司为担保公司提供反担保，担保金额 800 万元， 保证方式为不可撤销的连带反担保保证责任。 2. 担保事项二：史纪生物拟向成都银行龙泉驿支行申请 800 万元流 ...

证券代码：002141 证券简称：贤丰控股 公告编号：2025-075 贤丰控股股份有限公司 拟签订《关于解除饲料购销协议及其补充协议的协议》和《关 于解除租赁合同的协议》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司（以下简称"公司"）的控股孙公司遵义市康禧元动 物营养科技有限公司（以下简称"康禧元"）前期与遵义日泉饲料生物科技有限 公司及其股东广东天农集团股份有限公司（原用名：广东天农食品集团股份有限 公司）签订了《饲料厂租赁合同》，并与贵州湄潭日泉农牧有限公司、贵州桐梓 日泉农牧有限公司、贵州日泉种猪育种有限公司签订了《饲料购销协议》及补充 协议。详见公司 2024 年 11 月 5 日披露于巨潮资讯网（www.cninfo.com.cn）上 的《关于签订<饲料厂租赁合同>和<饲料购销协议>的公告》（公告编号：2024-122）。 2025 年 9 月 26 日公司召开第八届董事会第二十一次会议审议通过了《拟签 订<关于解除饲料购销协议及其补充协议的协议>和<关于解除租赁合同的协议> 的议案》，基于公司业务发展情况，现经各方 ...

第八届董事会第二十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1. 贤丰控股股份有限公司（以下简称"公司"）第八届董事会第二十一次 会议通知已提前以电话、邮件等方式发出。 2. 会议于 2025 年 9 月 26 日在公司会议室以现场与电子通信（线上会议） 相结合的方式召开。 3. 会议应参与表决董事 7 人，实际参与表决董事 7 人（其中董事丁晨先生、 谢文彬先生、万荣杰先生和独立董事肖世练先生、梁融先生以线上会议方式出 席）。 4. 会议由公司董事长韩桃子女士主持。 证券代码：002141 证券简称：贤丰控股 公告编号：2025-073 贤丰控股股份有限公司 5. 本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 二、董事会会议审议情况 特此公告。 1. 审议通过《关于为控股子公司向银行借款事项提供担保和反担保的议案》 表决结果：以 7 票赞成、0 票反对、0 票弃权的表决结果，通过本议案。 2. 审议通过《拟签订<关于解除饲料购销协议及其补充协议的协议>和<关 于解除租 ...

Core Viewpoint - The company, Xianfeng Holdings, is planning to exit the feed business through the termination of existing agreements with its partners, indicating a strategic shift in its business operations [1] Group 1: Company Actions - Xianfeng Holdings' subsidiary, Zunyi Kangxiyuan Animal Nutrition Technology Co., Ltd., has signed a feed factory lease contract and feed purchase agreements with several companies [1] - The company’s board of directors has approved the proposal to terminate the feed purchase agreements and the lease contract, reflecting a decision based on the company's business development situation [1] - The termination agreements will be signed following friendly negotiations with the counterparties, and the company will gradually complete the handover of related matters after the agreements are finalized [1] Group 2: Future Implications - The exit from the feed business suggests a potential refocus on other areas of operation, which may impact the company's future strategic direction and resource allocation [1] - The authorization of the chairman or designated agent to sign the termination documents indicates a streamlined process for the transition away from the feed business [1]